Bladder Scanners Market Size and Share
Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Market Size (2025) | USD 169.40 Million |
| Market Size (2030) | USD 227.77 Million |
| Growth Rate (2025 - 2030) | 6.10% CAGR |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Bladder Scanners Market Analysis by Mordor Intelligence
The Bladder Scanner Market currently stands at USD 169.40 million in 2025 and is projected to reach USD 227.77 million by 2030, reflecting a 6.10% CAGR over the forecast period. This trajectory underscores steady demand as aging populations, catheter-associated urinary tract infection (CAUTI) prevention mandates, and artificial-intelligence-enabled ultrasound technologies converge to redefine bedside bladder volume assessment. Heightened regulatory scrutiny from the Centers for Medicare & Medicaid Services (CMS) ties reimbursement to CAUTI metrics, prompting hospitals, ambulatory surgical centers (ASCs), and long-term-care facilities to prioritize non-invasive scanning devices. Clinical evidence supporting 79.5% concordance between point-of-care ultrasound (POCUS) findings and in-house diagnostics fuels rapid emergency-medicine uptake. Meanwhile, Verathon’s ImageSense AI engine achieves ±7.5% accuracy above 100 mL, satisfying payer demands for objective measurement. Capital constraints and operator-skill gaps continue to restrict penetration in rural and developing areas, yet flexible leasing models and simplified user interfaces are beginning to mitigate adoption barriers.
Key Report Takeawa
- By product type, 3D ultrasound scanners led with 52.69% of the Bladder Scanner market share in 2024.
- By portability, portable/cart-based devices accounted for 61.23% share of the Bladder Scanner market size in 2024 and are advancing at a 6.45% CAGR through 2030.
- By technology, conventional imaging commanded 67.51% share of the Bladder Scanner market size in 2024, while AI-enabled imaging is forecast to expand at 6.98% CAGR to 2030.
- By end user, hospitals and clinics held 72.95% of the Bladder Scanner market share in 2024; ASCs register the highest projected CAGR at 6.54% through 2030.
- By geography, North America captured 39.08% revenue share in 2024; Asia-Pacific is set to grow at 6.93% CAGR between 2025-2030.
Global Bladder Scanners Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Age-linked rise in urinary retention & CAUTI prevention mandates | +1.8% | Global, concentrated in North America & Europe | Medium term (2-4 years) |
| Point-of-care ultrasound adoption in emergency & peri-operative care | +1.2% | Global, with APAC acceleration | Short term (≤ 2 years) |
| AI-enabled 3D volume measurement driving reimbursement eligibility | +1.4% | North America & EU primary markets | Medium term (2-4 years) |
| Nursing-home CAUTI penalty programs accelerating procurement | +0.9% | North America, expanding to EU | Short term (≤ 2 years) |
| Hand-held plug-and-play models for low-resource clinics | +0.7% | APAC core, spill-over to MEA | Long term (≥ 4 years) |
| ERAS protocols replacing routine catheterisation with scanning | +1.0% | Global, led by North America & Europe | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Aging population and CAUTI-prevention mandates
Global life expectancy gains translate into higher urinary-retention incidence, prompting clinicians to adopt scanners that reduce unnecessary catheter insertions while preserving accuracy. CMS quality programs link payments to CAUTI outcomes, and facilities using bladder scanners have documented 80% catheter-reduction success, spotlighting the technology as a core infection-control tool.
Point-of-care ultrasound integration in emergency and peri-operative care
Handheld scanners achieve near-cart-based image quality, supporting rapid triage decisions where minutes matter. Enhanced Recovery After Surgery (ERAS) pathways further incentivize intra-operative scanning to limit catheter-associated complications and speed discharge timelines.
AI-enabled 3D volume measurement improving reimbursement eligibility
Automated boundary recognition removes operator subjectivity, raising diagnostic consistency and aligning with payer requirements for objective evidence before procedure authorization. Early adopters report more than USD 150,000 annual savings in 100-bed hospitals through avoided catheter-related UTIs[1]Source: Verathon, “Artificial Intelligence in Bladder Volume Measurement,” verathon.com .
Nursing-home CAUTI penalty programs
Updated CMS enforcement heightens financial exposure for facilities with high CAUTI rates, accelerating scanner procurement in long-term-care settings where urinary-tract infections boost lengths of stay by 3.01 days and add USD 9,807 per case.
Restraint Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High capital cost & limited budget in small practices | -1.1% | Global, acute in rural and developing regions | Short term (≤ 2 years) |
| Shortage of trained operators in rural settings | -0.8% | Rural areas globally, concentrated in APAC & MEA | Medium term (2-4 years) |
| Emerging low-cost wearable pressure-sensor substitutes | -0.9% | Global, early adoption in North America & Europe | Long term (≥ 4 years) |
| Inconsistent procedure-code reimbursement outside U.S. | -1.2% | International markets, excluding North America | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High capital cost and limited budgets in small practices
Base-model scanners cost USD 15,000–40,000, and service contracts can double lifetime outlay, discouraging adoption where reimbursements are low and patient volumes modest. Leasing and pay-per-use models are emerging, yet return-on-investment remains marginal for solo practitioners.
Shortage of trained operators in rural settings
Limited continuing-education access in remote areas constrains skill development, leading to suboptimal images and diagnostic hesitancy. Simplified UIs and AI guidance reduce learning curves, while tele-mentored ultrasound offers promise but depends on broadband coverage and regulatory alignment.
Segment Analysis
By Product Type: 3D technology refines precision medicine
3D scanners generated 52.69% of the Bladder Scanner market share in 2024 by delivering volumetric accuracy that conventional 2D models cannot match. The segment is forecast to expand at 6.12% CAGR to 2030 as evidence compares mean errors of 11.17% against catheter-derived volumes. 2D devices remain preferred where budgets are tight; however, AI-assisted algorithms have narrowed the gap, posting 0.97 correlation with expert measurements.
Growth momentum for 3D scanners hinges on reimbursement rules that increasingly mandate objective bladder-volume evidence, while declining component costs make premium models accessible beyond tertiary hospitals. In parallel, 2D systems target primary-care and screening settings by coupling lower price tags with cloud-based analytics that upgrade over time. Both categories reinforce the Bladder Scanner Market trajectory by meeting diverse accuracy-versus-affordability thresholds across geographies.
By Portability: Mobility transforms clinical workflows
Portable/cart-based systems held 61.23% of the Bladder Scanner market size in 2024 as many hospitals retain established imaging suites that favor wheeled devices. Nevertheless, handheld units are advancing at 6.45% CAGR, spurred by sub-2 lb form factors tethered to tablets or smartphones that facilitate bedside use in crowded emergency rooms.
The appeal of hand-carried models lies in faster patient turnover and reduced dependence on ultrasound technologists, a pivotal benefit for ASCs striving for same-day discharge. Bench-top scanners serve niche urology clinics that value compact, fixed workstations. Continuous-monitoring implants under university development hint at the next segmentation evolution, yet commercialization timelines place them beyond current Bladder Scanner Market revenue modeling.
By Technology: AI acceleration reshapes diagnostic standards
Conventional imaging platforms commanded 67.51% share in 2024; AI-enabled imaging is projected to outpace with 6.98% CAGR to 2030. Automated contour detection standardizes volume estimation, reducing inter-operator variability and shortening training cycles.
Cost-effective embedded processors and cloud connectivity are shifting AI from premium add-on to default specification. This convergence positions future systems to bundle real-time bladder tracking, archiving, and infection-control dashboards without major price premiums, supporting sustainable Bladder Scanner Market adoption across care settings.
By End User: ASCs lead adoption innovation
Hospitals and clinics retained 72.95% share of the Bladder Scanner market size in 2024, bolstered by integrated infection-control programs and institutional budgets[2]Source: Food and Drug Administration, “Medical Devices; Technical Amendments,” federalregister.gov . However, ASCs represent the fastest-growing segment at 6.54% CAGR as ERAS guidelines displace prophylactic catheterization with scanning, cutting postoperative UTI risks and enabling rapid discharge.
Diagnostic centers and long-term-care facilities constitute steady demand pools where aging demographics and CAUTI penalties intersect. Early home-health pilots explore wearable ultrasound for chronic neurogenic-bladder patients, but reimbursement gaps postpone near-term revenue contribution.
Note: Segment shares of all individual segments available upon report purchase
By Application: Emergency medicine drives innovation
Emergency-medicine use cases exhibit strong momentum owing to 79.5% alignment between POCUS bladder scans and subsequent in-hospital imaging, reducing diagnostic delays in acute urinary-retention scenarios. Urology remains the core application, while obstetrics & gynecology protocols integrate scanners to manage postpartum voiding deficits despite higher body-mass-index challenges.
Rehabilitation and physiotherapy clinics increasingly use bladder scanners for neurorehabilitation programs requiring frequent residual-volume checks. Additional applications span pediatrics, geriatrics, and oncology surveillance, collectively broadening clinical touchpoints and solidifying the Bladder Scanner Market user base.
Geography Analysis
North America generated 39.08% of global revenue in 2024, anchored by CMS payment models that reward CAUTI reduction and by widespread AI-enabled ultrasound familiarity among clinicians. Ongoing FDA quality-system updates slated for 2026 are expected to harmonize manufacturing benchmarks, reducing procurement risk for providers.
Asia-Pacific is forecast to post a 6.93% CAGR through 2030, underpinned by expanding healthcare investments and accelerating POCUS training programs. China and India spearhead volume demand as tertiary centers adopt 3D scanners for surgical wards, while Japan and South Korea emphasize AI algorithms that align with national digital-health strategies. Australia and Southeast-Asian markets favor portable units compatible with constrained clinical footprints.
Europe shows balanced growth amid CE-mark standardization and infection-prevention campaigns integrating bladder scanners into national quality frameworks. Germany, France, Italy, Spain, and the United Kingdom drive adoption based on public-insurance reimbursement, whereas Central and Eastern European countries adopt through donor-funded procurement. South America and Middle East & Africa remain nascent yet promising as infrastructure upgrades prioritize affordable, easy-to-train modalities in high-burden urological settings.
Competitive Landscape
The Bladder Scanner Market displays moderate concentration. Verathon dominates with its BladderScan portfolio and proprietary ImageSense AI, which validates ±7.5% accuracy at clinically relevant volumes. Laborie Medical Technologies, Mindray Bio-Medical Electronics, and GE HealthCare pursue ecosystem strategies that embed bladder modules within broader ultrasound or patient-monitoring platforms.
New entrants leverage FDA 510(k) approvals to commercialize AI-native handheld devices, as seen with Clarius Mobile Health’s Bladder AI clearance in January 2024. Continuous-monitoring prototypes from Northwestern University hint at disruptive potential, while wearable-sensor startups collaborate with textile firms to test pressure-based alternatives in post-acute care.
Strategic moves center on acquisitions and product-line expansions. Boston Scientific’s USD 3.7 billion Axonics purchase expands its urology franchise into implantable solutions. Medtronic’s Hugo robotic surgery submission highlights convergence between surgical robotics and diagnostic imaging, potentially integrating bladder-volume checks into procedure workflows. As AI capabilities standardize, competition is likely to pivot toward connectivity, cybersecurity, and lifetime service offerings rather than solely imaging accuracy.
Bladder Scanners Industry Leaders
-
GE Healthcare Inc
-
Roper Technologies Inc. (Verathon Inc.)
-
Mcube Technology Co. Ltd
-
Vitacon
-
dBMEDx
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2024: Medtronic submitted its Hugo robotic-assisted surgery platform to the FDA for urologic use and reported USD 8.9 billion Q4 FY25 revenue
- April 2025: Bright Uro received FDA clearance for Glean, a wireless catheter-free urodynamics system
Global Bladder Scanners Market Report Scope
As per the scope of the report, a bladder scanner is a non-invasive ultrasound device or a tool that provides a virtual two or three-dimensional (3D) or (2D) image of the bladder and the volume of urine retained within the bladder for diagnosing, managing and treating urinary outflow dysfunction. The bladder scanner market is segmented by product, end-user, and geography. By product, the market is segmented into bench-top bladder scanners, portable bladder scanners, and handheld bladder scanners. By end user, the market is segmented into hospitals, diagnostic centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD) for the above segments.
| Resting ECG Systems |
| Stress ECG Systems |
| Holter Monitors |
| Event Recorders |
| Wearable / Patch ECG Devices |
| ECG Management Software |
| Single-Lead ECG |
| 3–6 Lead ECG |
| 12-Lead ECG |
| 15/18-Lead Advanced ECG |
| Hospitals & Clinics |
| Ambulatory Surgical Centers |
| Home Settings / Remote Patients |
| Diagnostic Labs & Cardiac Centers |
| Analog ECG Devices |
| Digital / Cloud-connected ECG Devices |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product Type | Resting ECG Systems | |
| Stress ECG Systems | ||
| Holter Monitors | ||
| Event Recorders | ||
| Wearable / Patch ECG Devices | ||
| ECG Management Software | ||
| By Lead Type | Single-Lead ECG | |
| 3–6 Lead ECG | ||
| 12-Lead ECG | ||
| 15/18-Lead Advanced ECG | ||
| By End User | Hospitals & Clinics | |
| Ambulatory Surgical Centers | ||
| Home Settings / Remote Patients | ||
| Diagnostic Labs & Cardiac Centers | ||
| By Technology | Analog ECG Devices | |
| Digital / Cloud-connected ECG Devices | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
What is the 2025 valuation of the Bladder Scanner Market?
The Bladder Scanner Market is valued at USD 169.40 million in 2025.
What is the 2025 valuation of the Bladder Scanner Market?
It is forecast to expand at a 6.10% CAGR, reaching USD 227.77 million by 2030.
Which product category leads in revenue share?
3D ultrasound scanners held 52.69% of global revenue in 2024.
Which region is growing the quickest?
Asia-Pacific is projected to grow at a 6.93% CAGR between 2025-2030.
Why are ASCs important to future demand?
Ambulatory Surgical Centers adopt scanners to comply with ERAS protocols, enabling non-invasive monitoring and supporting a 6.54% CAGR in this setting.
How does AI benefit bladder scanning?
AI automates bladder-boundary detection, delivering ±7.5% accuracy and reducing operator training time, which in turn improves reimbursement eligibility.
Page last updated on:
